Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
Myeloid Therapeutics
Myeloid Therapeutics
Incyte Corporation
Novartis
Avenzo Therapeutics, Inc.
Pfizer
Nurix Therapeutics, Inc.
Xencor, Inc.
858 Therapeutics, Inc.
Medicenna Therapeutics, Inc.
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Dana-Farber Cancer Institute
Instituto do Cancer do Estado de São Paulo
Klus Pharma Inc.
Theratechnologies
University of Washington
Exelixis
University Health Network, Toronto